---
figid: PMC3406244__nihms369094f3
figlink: /pmc/articles/PMC3406244/figure/F3/
number: Figure 3
caption: (i). PV decreases peroxisome proliferator–activated receptor γ (PPARγ) activity
  by competition with PPARγ for binding to PPARγ response elements (PPRE) as heterodimers
  with PPARγ or the retinoid X receptor (RXR). Repressed transcriptional activity
  of PPARγ leads to increase cancer cell proliferation and decrease apoptosis in thyroids
  of ThrbPV/PV mice. (ii) PV activates phosphatidylinositol 3-kinase (PI3K) signaling
  pathway by physical interaction with the regulatory subunit of PI3K (p85α). Over-activation
  of PI3K-Akt signaling increases proliferation and migration of cancer cells and
  decreases apoptosis via the downstream pathways as shown. (iii) PV activates integrin-Src-focal
  adhesion kinase (FAK) signaling cascade. PV interacts with integrin and activates
  phosphorylation of Src and FAK. Activated Src-FAK signaling pathway induces epithelial-mesenchymal
  transition (EMT) and activation of matrix metalloproteases (MMPs) to increase cell
  migration, invasion and distant metastasis. Activated Src also potentiates mitogen-activated
  protein kinase (MAPK) signaling to increase cell proliferation and EMT. (iv) PV
  inhibits proteasomal degradation of the pituitary tumor transforming gene (PTTG)
  and β-catenin. PV binds to PTTG and prevents its degradation by proteasome, resulting
  in accumulation of PTTG. Elevated PTTG impedes mitotic progression, leading to chromosomal
  aberrations. Elevated PTTG, via transcription activation of its target genes, increases
  cell proliferation and augments angiogenesis. PV also increases the stability of
  β-catenin via direct protein-protein interaction, thereby inhibiting protesomal
  degradation of β-catenin. Elevated β-catenin protein levels increase transcription
  activation of its downstream target genes that affect cell proliferation and migration.
pmcid: PMC3406244
papertitle: Thyroid Hormone Receptors and Cancer.
reftext: Won Gu Kim, et al. Biochim Biophys Acta. ;1830(7):3928-3936.
pmc_ranked_result_index: '15013'
pathway_score: 0.9436052
filename: nihms369094f3.jpg
figtitle: Thyroid Hormone Receptors and Cancer
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3406244__nihms369094f3.html
  '@type': Dataset
  description: (i). PV decreases peroxisome proliferator–activated receptor γ (PPARγ)
    activity by competition with PPARγ for binding to PPARγ response elements (PPRE)
    as heterodimers with PPARγ or the retinoid X receptor (RXR). Repressed transcriptional
    activity of PPARγ leads to increase cancer cell proliferation and decrease apoptosis
    in thyroids of ThrbPV/PV mice. (ii) PV activates phosphatidylinositol 3-kinase
    (PI3K) signaling pathway by physical interaction with the regulatory subunit of
    PI3K (p85α). Over-activation of PI3K-Akt signaling increases proliferation and
    migration of cancer cells and decreases apoptosis via the downstream pathways
    as shown. (iii) PV activates integrin-Src-focal adhesion kinase (FAK) signaling
    cascade. PV interacts with integrin and activates phosphorylation of Src and FAK.
    Activated Src-FAK signaling pathway induces epithelial-mesenchymal transition
    (EMT) and activation of matrix metalloproteases (MMPs) to increase cell migration,
    invasion and distant metastasis. Activated Src also potentiates mitogen-activated
    protein kinase (MAPK) signaling to increase cell proliferation and EMT. (iv) PV
    inhibits proteasomal degradation of the pituitary tumor transforming gene (PTTG)
    and β-catenin. PV binds to PTTG and prevents its degradation by proteasome, resulting
    in accumulation of PTTG. Elevated PTTG impedes mitotic progression, leading to
    chromosomal aberrations. Elevated PTTG, via transcription activation of its target
    genes, increases cell proliferation and augments angiogenesis. PV also increases
    the stability of β-catenin via direct protein-protein interaction, thereby inhibiting
    protesomal degradation of β-catenin. Elevated β-catenin protein levels increase
    transcription activation of its downstream target genes that affect cell proliferation
    and migration.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R5
  - PIK3CA
  - MAPK11
  - MTOR
  - PIK3R1
  - MAPK3
  - PIK3R4
  - RXRB
  - MMP2
  - MMP9
  - PIK3R6
  - AKT2
  - MAPK14
  - MAPK1
  - CP
  - MAPK9
  - MAP2K2
  - AKT1
  - PIK3CB
  - MAP2K1
  - CASP1
  - CTNNB1
  - RXRG
  - MAPK8
  - CASP7
  - MAPK10
  - SP1
  - CASP10
  - CASP12
  - CASP8
  - CASP9
  - PTK2
  - PIK3R3
  - SRC
  - ELL
  - PIK3CG
  - AKT3
  - MAPK12
  - PIK3CD
  - RXRA
  - CASP4
  - MAPK13
  - PTTG1
  - CASP14
  - CASP6
  - CASP5
  - CASP2
  - CASP3
  - Cancer
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: p85a
  symbol: p85-ALPHA
  source: hgnc_alias_symbol
  hgnc_symbol: PIK3R1
  entrez: '5295'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRB
  entrez: '6257'
- word: MMP2/
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: MMP9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CP
  symbol: CP
  source: hgnc_symbol
  hgnc_symbol: CP
  entrez: '1356'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRG
  entrez: '6258'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: SP1
  symbol: SP1
  source: hgnc_symbol
  hgnc_symbol: SP1
  entrez: '6667'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: ell
  symbol: ELL
  source: hgnc_symbol
  hgnc_symbol: ELL
  entrez: '8178'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: RXR
  symbol: RXR
  source: bioentities_symbol
  hgnc_symbol: RXRA
  entrez: '6256'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PTTG
  symbol: PTTG
  source: hgnc_alias_symbol
  hgnc_symbol: PTTG1
  entrez: '9232'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
